Welcome to The Healthy Nudge. Each month, we'll get you up to speed on the latest developments in policy-relevant health behavioral economics research at CHIBE.
|
|
"New medications that target biological mechanisms to address obesity, diabetes and related cardiometabolic conditions are widely popular. As not everyone is eligible, willing or able to take medications, structural and behavioral solutions remain essential to treat and decrease the risk of cardiometabolic diseases." This paper explains why behavior change is still critical in the era of expanded biomedical options.
|
|
"There are no easy solutions to a health crisis that stems, at least in part, from people’s choices about what to eat. But one approach that many health authorities have tried is the adoption of front-of-package (FOP) labels. The idea is not simply to alert consumers to the risks of different foods, but also to motivate companies to reformulate products."
CHIBE Associate Director Christina Roberto, PhD, weighs in on FOP food labeling, saying, "We have a really massive public health crisis, where essentially the industry controls our food supply. So the notion of informing the public about what’s in their food, I find it very hard to argue against that." Read more here.
|
|
"Effective HIV prevention and treatment are widely available, but services are underused and underdelivered. Behavioral economics offers insights into why this is and shows us cost-effective interventions to change behaviors. We call for investment in scaling up behavioral economics approaches to aid in progress towards ending HIV." Read the paper here.
|
|
A Knowledge at Wharton article featuring CHIBE-affiliated faculty member Katy Milkman, PhD
“There’s this widely spread rumor that it takes 21 days to form a habit. You may have also heard it takes 90 days to form a habit. There are popular books that tout these numbers that don’t have a sound basis in research. What we find is there is no such magic number,” said Katy Milkman, PhD. Read more here.
|
|
A Journal of Clinical Oncology paper led by CHIBE-affiliated faculty member Brian Jenssen, MD, MSHP, with CHIBE authors Rinad Beidas, PhD (Associate Director of CHIBE); Justin Bekelman, MD; David Asch, MD, MBA; Alison Buttenheim, PhD, MBA (Scientific Director of CHIBE); Frank Leone, MD, MS, et al.
"Few cancer centers systematically engage patients with evidence-based tobacco treatment despite its positive effect on quality of life and survival. [This paper found that] EHR nudges, informed by behavioral economics and aimed at oncology clinicians, appear to substantially increase tobacco use treatment penetration. Adding patient nudges to the implementation strategy did not affect tobacco use treatment penetration rates." Read more here.
|
|
Register for the Nudges in Health Care Symposium: September 14-15!
The keynote speakers will be CHIBE Director Kevin Volpp, MD, PhD, and Elizabeth Linos, PhD, the Emma Bloomberg Associate Professor for Public Policy and Management, and Faculty Director of The People Lab at the Harvard Kennedy School of Government. Learn more and register here.
|
CHIBE and Penn's Department of Medical Ethics & Health Policy is seeking several highly motivated Research Coordinator A/Bs to be responsible for the day-to-day execution of innovative research and Patient Navigator activities for a program that adapts and evaluates existing behavioral science approaches to reduce atherosclerotic cardiovascular disease (ASCVD) risk for Penn Medicine patients. The Penn Medicine Healthy Heart program adapts existing behavioral science evidence as well as novel patient, physician, and health system approaches to identify, diagnose and treat patients at elevated ASCVD risk and improve hypertension management, lower cholesterol, increase healthy eating, and achieve smoking cessation. The Penn Medicine Healthy Heart Program will be tested in a large, randomized control trial focused on patients in West and Southwest Philly and in Lancaster, PA, and refined through rapid cycle/quality improvement pilot testing. Essential functions of this position will include but are not limited to: enrollment of participants; patient navigation/liaison services for uptake of four modules including home blood pressure monitoring, statin uptake, nutrition and smoking cessation. As patient navigator they will: facilitate protocol-based medication initiation and titration to help patients achieve BP and LDL goals; provide education regarding home BP monitoring, cholesterol, and lifestyle management guidelines; pend medication prescriptions and laboratory testing orders for review and approval by supervising physicians; refer cases to supervising physicians for review and decision making. As a member of the research team they will engage in quantitative and qualitative data collection and management in accordance with pilot and study protocols; follow all IRB and human subjects policies and regulations; perform chart reviews; prepare and manage study/pilot-related materials and documentation; conduct participant interviews and support feedback sessions to solicit patient feedback to evaluate and improve the program. Apply here.
|
|
|
|
|
|
|
